Effect of addition of anti-inflammatory medication to anti-depressant medication on C-reactive protein levels in the treatment of depression
Phase of Trial: Phase IV
Latest Information Update: 27 Jul 2018
At a glance
- Drugs Celecoxib (Primary) ; Vortioxetine
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms PREDDICT
- 20 Jul 2018 Status changed from not yet recruiting to recruiting.
- 08 Aug 2017 Planned End Date changed from 31 Jan 2019 to 15 Apr 2019.
- 08 Aug 2017 Planned initiation date changed from 15 Jun 2017 to 28 Aug 2017.